News | News By Subject | News by Disease News By Date | Search News

Male Erectile Dysfunction (MED) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Apricus Biosciences (APRI)'s Fispemifene Missed Primary, Secondary Objectives in Phase IIb Study     3/28/2016
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA     1/23/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant     1/14/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval     9/19/2014
EU Approves VIVUS, Inc. (VVUS)'s Erectile Dysfunction Drug Spedra     6/27/2013
VIVUS, Inc. (VVUS) Study Shows ED Drug Stendra Effective in 15 Minutes     6/19/2013
Apricus Biosciences (APRI) Says Vitaros Gets European Approval for Erectile Dysfunction     6/10/2013
Trimel Pharmaceuticals P3 Shows Statistically Significant Improvement on Erectile Function and Mood     3/18/2013
FDA OKs VIVUS (VVUS)'s Fast-acting Viagra Rival     5/1/2012
South Korea to Approve Pfizer Inc. (PFE)'s Viagra Generics     3/15/2012
Sandoz, Inc. Buys German Rights to Apricus Biosciences (APRI)' Sex Drug for $28 Million     2/16/2012
Regeneca International, Inc. Recalls Specific Lot of RegenArouse Because of Potential Health Risks     2/13/2012

News from Around the Web
Sound Wave Therapy Is First Alternative To Viagra In 15 Years     2/19/2016
Blueberries And Red Wine Can Help With Erectile Dysfunction, University of East Anglia Study     1/14/2016
Drinking Coffee May Lower Erectile Dysfunction Risk, University of Texas Health Science Center Study     5/22/2015
Viagra To Prevent Transmission Of The Malaria Parasite? INSERM Study     5/8/2015
Viagra, Other ED Drugs Not a Universal Cure For All Impotence     4/8/2015
Liposuction Byproduct Could Lead To ED Cure, University Of Ulsan College Of Medicine And Asan Medical Center Study     3/20/2015
A Man's Relationship With Mom Could Cause Erectile Dysfunction, Charles University Study     1/8/2015
Mediterranean Diet Linked To Improved CV Function In Erectile Dysfunction Patients, Hippokration Hospital Study     12/3/2014
Viagra Poses Cancer Risk For Men, JAMA Reveals     6/6/2014
Erectile Dysfunction Treatment: 6 Ways To Overcome Impotence Naturally     5/9/2014
Viagra Ice Cream: New Flavor Contains Sildenafil Citrate     4/16/2014
Erectile Dysfunction Can Be Reversed? University of Adelaide Study     4/1/2014
Fake Erectile Dysfunction Pill May Harm Men: FDA     11/13/2013
Porn-Induced Erectile Dysfunction Is A Growing Problem, University of Padua Study     6/21/2011
Restless Legs Syndrome Linked to Erectile Dysfunction, Harvard University Study     6/16/2011

Press Releases
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance From U.S. Patent And Trademark Office For Erectile Dysfunction Drug     11/10/2016
Apricus Biosciences (APRI) Announces Approval Of Vitaros For The Treatment Of Erectile Dysfunction In Greece     10/26/2016
Apricus Biosciences (APRI) Announces The Launch Of Vitaros In The Czech Republic And Slovakia By Recordati     9/21/2016
iX Biopharma Announces Positive Results From Pivotal Study Of Erectile Dysfunction Drug     9/14/2016
Apricus Biosciences (APRI) Announces Approval Of Vitaros For The Treatment Of Erectile Dysfunction In Argentina     9/8/2016
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Portugal, Ireland And Poland By Recordati     9/6/2016
Men Claim Eli Lilly (LLY)'s Sexual Dysfunction Drug Cialis Tied to Skin Cancer in Lawsuit     8/8/2016
Apricus Biosciences (APRI) To Host Live Webcast KOL Event On May 9th Addressing Vitaros And Erectile Dysfunction Population     5/4/2016
Apricus Biosciences (APRI) To Host Live Webcast KOL Event On May 9th Addressing Vitaros And Erectile Dysfunction Population     5/3/2016
Can-Fite BioPharma (CFBI) Announces New Pre-Clinical Data For CF602 Demonstrating Statistically Significant Full Recovery From Erectile Dysfunction After A Single Dose     4/11/2016
Can-Fite BioPharma (CFBI) Reports 2015 Financial Results & Provides Clinical Pipeline Update     4/1/2016
Can-Fite BioPharma (CFBI) To Present At BIO CEO & Investor Conference In New York City On February 8, 2016     2/5/2016
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Italy By Bracco SpA     9/1/2015
Apricus Biosciences (APRI) Announces Approval Of Vitaros For The Treatment Of Erectile Dysfunction In Twelve Additional Countries     8/10/2015
Strategic Science & Technologies Initiates Phase II Study To Evaluate Topical Sildenafil In Men With Erectile Dysfunction     6/17/2015

//-->